Heartflow Sues Cardiac AI Rival Cleerly Over Alleged IP Theft
HeartFlow, which makes AI tools to analyze cardiac images, sued its rival Cleerly, alleging infringement on six patents. Cleerly is pushing back.
Generics companies face risk as SCOTUS questions patent tribunal’s constitutionality
The U.S. Supreme Court heard oral arguments Monday on the constitutionality of the Patent Trial and Appeal Board, an essential piece of the United States patent litigation puzzle and favored tool of generic and biosimilar patent challengers since its formation in 2012.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
Drug patents expiring in 2017? It’s all smoke and mirrors
What drug patents are set to expire in 2017? It's hard to know. With so many 'evergreening' patent strategies and the added complexity of biologics and biosimilars, the proverbial patent cliff is becoming a thing of the past.